Jul 23, 2026 08:04AM
Jul 23, 2026 08:00AM
Mar 31, 2026 05:05PM
Feb 19, 2026 05:31PM
Feb 13, 2026 08:30AM
Feb 13, 2026 08:30AM
Nov 18, 2025 07:25AM HCW Biologics begins first human trial of HCW9302 for autoimmune disease
Nov 18, 2025 07:25AM
Nov 14, 2025 04:44PM
Sep 9, 2025 08:01AM
Sep 9, 2025 08:00AM
Aug 25, 2025 08:23AM
Aug 25, 2025 08:00AM
Aug 18, 2025 02:44PM HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
Jun 27, 2025 07:50AM
Jun 27, 2025 07:45AM
May 15, 2025 06:14PM
May 13, 2025 08:31AM
May 13, 2025 08:30AM
Apr 1, 2025 04:36PM
Apr 1, 2025 04:35PM HCW Biologics Announces 1-for-40 Reverse Stock Split
Mar 28, 2025 03:30PM
Feb 3, 2025 07:16AM
Feb 3, 2025 07:15AM
Nov 14, 2024 04:40PM
Aug 23, 2024 04:30PM
Aug 14, 2024 04:35PM
May 15, 2024 04:39PM HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
Nov 7, 2022 09:34AM
Aug 12, 2022 07:00AM
Aug 3, 2022 07:23AM
Aug 3, 2022 07:15AM
May 23, 2022 07:30AM
May 13, 2022 07:15AM
May 13, 2022 07:15AM HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 5, 2022 07:30AM
May 5, 2022 07:30AM
Apr 19, 2022 07:33AM
Apr 19, 2022 07:33AM
Mar 28, 2022 07:00AM
Mar 28, 2022 07:00AM
Mar 24, 2022 08:00AM HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
Mar 24, 2022 08:00AM
Jan 24, 2022 07:04AM
Jan 24, 2022 07:00AM
Jan 24, 2022 07:00AM
Jan 20, 2022 08:05AM
Jan 20, 2022 08:00AM
Jan 20, 2022 08:00AM HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens
Jan 19, 2022 08:00AM

326,538 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All